By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
"Let's hear from the visionary himself."
That’s how Leonard Schleifer, M.D., Ph.D., founder, president, and CEO of Regeneron responded when asked at this year’s JPM conference about the “bluesky scenario” of the Regeneron Genetics Center (RGC). The question prompting this response came during the company’s breakout session, and I had a front-row seat for the exchange.